Vagal effects of endocrine HPA axis challenges on resting autonomic activity assessed by heart rate variability measures in healthy humans
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 102, 196-203
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Implementing false discovery rate control: increasing your powerOikos, 2005
- When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related DisordersAmerican Journal of Psychiatry, 2003
- CRH Signalling in the Bed Nucleus of the Stria Terminalis is Involved in Stress-Induced Cardiac Vagal Activation in Conscious RatsNeuropsychopharmacology, 2001
- A model of neurovisceral integration in emotion regulation and dysregulationJournal of Affective Disorders, 2000
- The Role of the CRH Type 1 Receptor in Autonomic Responses to Corticotropin- Releasing Hormone in the RatNeuropsychopharmacology, 2000
- A comparison of the overnight and the standard metyrapone test for the differential diagnosis of adrenocorticotrophin-dependent Cushing’s syndromeClinical Endocrinology, 1996
- Neuroendocrinology and Pathophysiology of the Stress SystemAnnals of the New York Academy of Sciences, 1995
- The overnight single‐dose metyrapone test is a simple and reliable index of the hypothalamic‐pituitary‐adrenal axisClinical Endocrinology, 1994
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- The normal range and determinants of the intrinsic heart rate in manCardiovascular Research, 1970